Impact of HCV eradication on recurrence pattern and long‐term outcomes in patients with HCV‐related hepatocellular carcinoma undergoing radiofrequency ablation

Documenti analoghi

• Letter: Impact of HCV Eradication on Recurrence Pattern and Long‐Term Outcomes in Patients With HCV‐Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Authors' Reply
  di: Kuo‐Cheng Wu, et al.
  Pubblicazione: (2024)
• Letter: ‘Impact of HCV Eradication on Recurrence Pattern and Long‐Term Outcomes in Patients With HCV‐Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation’
  di: You‐Jian Xu, et al.
  Pubblicazione: (2024)
• Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver‐related mortality in patients with diabetes
  di: Xianhua Mao, et al.
  Pubblicazione: (2024)
• Editorial: Immune Checkpoint Inhibitors and HBV Reactivation in Liver Cancer—Reassurance With Vigilance
  di: Romeo Kuo‐Cheng Wu, et al.
  Pubblicazione: (2025)
• Letter: Post‐HCV Cure, Precision Assessment of Liver Stiffness and Diabetes Risk in Maternal Populations—A Critical Research Need
  di: Zihe Guan, et al.
  Pubblicazione: (2025)